Does your doctor know enough about drugs?

Does anyone? Drug prohibition is getting in the way of psychoactive drugs research How can you answer a question if the answer doesn’t exist? Let’s examine the case of *Fiona. She had previously experienced depression and thanks to therapy and medication was now symptom-free for over a year. However, after taking MDMA on a night … Continued

On War and Drugs

Like the thick smoky aftertaste that lingers after bonfire night merrymaking, memory hangs heavy in the air during the early weeks of November in the UK. As the oppressive darkness of the ironically named daylight-savings time settles in, we cast our collective memory back to the foiled attempt at Gunpowder Treason in 1605. More poignantly, … Continued

Strengthening the European Psychedelic Ecosystem: Partnership Between Octarine Bio and Clerkenwell Health

  The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe.  Clerkenwell Health … Continued

Opinion: Is the psychedelic movement elitist?

  There is no doubt that psychedelics hold incredible healing potential to treat mental illnesses. Their ability is so great, claims circulate that they can ‘cure’ conditions, a term almost unheard of in psychiatry. The psychedelic movement has highlighted the vast benefits of these currently controlled substances, helping to liberalise and destigmatise them. It has … Continued

Opinion: Current Psychedelic Research Lacks Diversity

  Psychedelics are making a comeback. We’ve recently witnessed a wave of re-emerging interest and research into psychedelic drugs. This has undoubtedly been a beneficial force for breaking down stigma, whilst highlighting the incredible potential psychedelics have for healing deep-rooted trauma. However, a narrative that isn’t addressed nearly enough is that our psychedelic research perpetuates … Continued

How COVID-19 will Affect the Psychedelic Renaissance

  Following the SARS virus outbreak in 2003, various studies detailed increased cases of depression and post-traumatic stress disorder. As the outbreak of the current COVID-19 pandemic, a coronavirus similar to SARS, continues to wreak havoc across the planet, an opinion piece in The Sacramento Bee suggests psychedelic therapy as a means to treat emotional … Continued